EFH
RPRX icon

Eaton Financial Holdings’s Royalty Pharma RPRX Stock Holding History

Eaton Financial Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50,592
Closed -$1.42M – 139
2023
Q4 		$1.42M Sell
50,592
-2,757
-5% -$75.8K 0.34% 79
2023
Q3 		$1.45M Buy
+53,349
New +$1.58M 0.39% 72

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Eaton Financial Holdings's RPRX Position: Q1 2024 in Review

Eaton Financial Holdings sold out of Royalty Pharma (RPRX) in Q1 2024, closing a stake of 50,592 shares — an estimated $1.42M sold.

Eaton Financial Holdings first reported a position in RPRX in Q3 2023 and held it in 2 quarters. The position peaked at $1.45M in Q3 2023. 378 funds tracked by Wall St. Rank hold RPRX as of Q1 2024.

  • Eaton Financial Holdings reported no remaining Royalty Pharma position as of Q1 2024 after selling out during the quarter.
  • Eaton Financial Holdings sold 50,592 Royalty Pharma shares in Q1 2024, an estimated $1.42M.
  • Eaton Financial Holdings first reported a position in Royalty Pharma in Q3 2023 and held it in 2 quarters.
  • Eaton Financial Holdings's Royalty Pharma position peaked at $1.45M in Q3 2023.
  • 378 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2024.

Based on Eaton Financial Holdings's 13F filing for Q1 2024, filed 19 Apr 2024.